- 5.2Impact Factor
- 10.5CiteScore
- 16 daysTime to First Decision
Advanced Research in Oral Oncology
Special Issue Information
Dear Colleagues,
Today, specific medical treatments are applied to improve the lives of patients living with head and neck cancer, including oral squamous carcinoma, all over the world. However, the mortality rate remains high among these patients, especially those in stage 4. To date, the analysis of molecular biology signaling has fostered a better understanding of the research findings that can help us to mediate oral squamous carcinoma with respect to apoptosis, autophagosis, pyroptosis, or ferroptosis. Meanwhile, these findings can inform new concepts for the design and application of anti-cancer drugs. However, many problems inhibiting our efforts to combat the disease still remain unresolved. In this Special Issue, we intend to publish manuscripts focusing on, but not limited to, topics related to advanced anti-cancer drug development, precision medicine, the application of herbs and natural compounds, drug delivery, microbiota in oral cancer patients, the mechanisms of carcinogenesis in oral oncology, radio-chemo-resistant mechanisms, and photodynamic and sonodynamic therapies. Therefore, we are pleased to invite researchers to submit work on these topics in the field of oral oncology, with the aim of updating the therapeutics. We look forward to receiving your contributions.
Prof. Dr. Tzong-Ming Shieh
Dr. Yin-Hwa Shih
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cells is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- anti-cancer drugs
- autophagosis
- carcinogenesis
- exosome
- ferroptosis
- microbiota
- photodynamic and sonodynamic therapies
- precision medicine
- pyroptosis
- radio-chemo-resistant
- target therapy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

